Biological Intellectual Property Protection Act of 2025

This bill requires U.S. exporters to obtain a license before sending digital sequences of human- or AI-designed synthetic DNA or RNA to "foreign entities of concern" (such as entities tied to specific countries like China). It directly affects biotechnology companies, researchers, and academic institutions that export these digital genetic blueprints. The key mechanism is a new license requirement for exporting the digital files representing synthetic biological sequences, which are defined as binary files or digital representations of DNA/RNA molecules. This policy change aims to prevent foreign adversaries from accessing U.S. biotechnology research and intellectual property through export channels.